jpmorgan analysts on the same call downgraded navistar.t's not helping today, do down .7%. >> up next, a pharmaceutical, a name that could also have been our under the radar pick. >> this is the call we referenced. this stock is down 9% this year so it's not getting crushed but is still down. they called a recent sell-off unwarranted. they see a lot of catalyst this year. their target is $160 a share. the stock's at $90 so not quite a double, about an 81% return. >> this is our final stock. polycorps. bit of an under the radar name. >> a charlotte, north carolina based maker of microporous membranes. >> what do they do? >> they are used in lithium batteries. the lithium battery market will surge. they raise it to a buy. their target on ppo is $60 a share, stock's at $47.22. lot of upside. you can do the math. there you go. >>> hash tag, get ready. twitter reporting earnings after the bell today or at least results. not sure they will be earnings, per se. herb greenberg says it is not revenue that really matters. what it is and why he cares